Review





Similar Products

94
R&D Systems clone ucht1
Clone Ucht1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/Human+CD3+epsilon+Antibody/pmc13761384-42-19-21
Average 94 stars, based on 1 article reviews
clone ucht1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Bio X Cell anti human cd3
Anti Human Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/InVivoMAb+anti-human+CD3/pm42987830-188-6-10
Average 95 stars, based on 1 article reviews
anti human cd3 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Biogems International anti cd3
Anti Cd3, supplied by Biogems International, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/Anti-Human+CD3+SAFIRE+Purified/pm42988853-129-35-37
Average 94 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Bio X Cell plate bound anti cd3
Plate Bound Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/InVivoMAb+anti-mouse+CD3/pm42980613-57-19-23
Average 96 stars, based on 1 article reviews
plate bound anti cd3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd3 antibodies
Anti Cd3 Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/CD8a+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__11__03__763975-36-3-5
Average 95 stars, based on 1 article reviews
anti cd3 antibodies - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Bio X Cell anti cd3ε antibodies
Proliferation and cytokine production of CD4 + and CD8 + T cells (A and C) Wild-type and NLK-deficient T cells were stimulated with 2 μg/mL plate-bound anti-CD3 with (++) or without (+) 1 μg/mL soluble anti-CD28. (A) Proliferation was measured via [3H]-thymidine uptake. (B) Wild-type and NLK-deficient lymph node and spleen cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28. Proliferation was analyzed by flow cytometry based on CFSE dilution after three days. (C) IL-2 secretion by CD4 + cells and IFN-γ secretion by CD8 + cells was determined with Bio-Plex after one day of stimulation. (D) Wild-type and NLK-deficient CD8 + T cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 6 h or left unstimulated. IFN-γ expression was determined by RT-qPCR and depicted as relative amount to GAPDH; n = 5. Data are represented as mean ± SEM. Paired t test; ∗ p < 0.05.
Anti Cd3ε Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/InVivoMAb+anti-human+CD3/pmc13755957-535-16-18
Average 95 stars, based on 1 article reviews
anti cd3ε antibodies - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc cd3
Proliferation and cytokine production of CD4 + and CD8 + T cells (A and C) Wild-type and NLK-deficient T cells were stimulated with 2 μg/mL plate-bound anti-CD3 with (++) or without (+) 1 μg/mL soluble anti-CD28. (A) Proliferation was measured via [3H]-thymidine uptake. (B) Wild-type and NLK-deficient lymph node and spleen cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28. Proliferation was analyzed by flow cytometry based on CFSE dilution after three days. (C) IL-2 secretion by CD4 + cells and IFN-γ secretion by CD8 + cells was determined with Bio-Plex after one day of stimulation. (D) Wild-type and NLK-deficient CD8 + T cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 6 h or left unstimulated. IFN-γ expression was determined by RT-qPCR and depicted as relative amount to GAPDH; n = 5. Data are represented as mean ± SEM. Paired t test; ∗ p < 0.05.
Cd3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/CD3epsilon+XP+Rabbit+mAb/pm42967934-424-5-6
Average 96 stars, based on 1 article reviews
cd3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Novus Biologicals primary antibodies against cd3
Proliferation and cytokine production of CD4 + and CD8 + T cells (A and C) Wild-type and NLK-deficient T cells were stimulated with 2 μg/mL plate-bound anti-CD3 with (++) or without (+) 1 μg/mL soluble anti-CD28. (A) Proliferation was measured via [3H]-thymidine uptake. (B) Wild-type and NLK-deficient lymph node and spleen cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28. Proliferation was analyzed by flow cytometry based on CFSE dilution after three days. (C) IL-2 secretion by CD4 + cells and IFN-γ secretion by CD8 + cells was determined with Bio-Plex after one day of stimulation. (D) Wild-type and NLK-deficient CD8 + T cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 6 h or left unstimulated. IFN-γ expression was determined by RT-qPCR and depicted as relative amount to GAPDH; n = 5. Data are represented as mean ± SEM. Paired t test; ∗ p < 0.05.
Primary Antibodies Against Cd3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/CD3+Antibody+(SP7)/pm42976399-80-0-7
Average 95 stars, based on 1 article reviews
primary antibodies against cd3 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Bio X Cell anti cd3 antibody
( A) Quantitative Analysis of Splenic T Cell Percentages. Line graph tracking the percentage of CD4 + and CD8 + T cells in the spleen from Mock through 4 dpi and 8 dpi. (B) Flow Cytometric Validation of CD4/CD8 Frequency. Representative dot plots showing CD4 vs . CD8 expression in Mock and DV-2 4 dpi spleen samples. (C) The bar graph (right) quantifies the fold change (FC) in CD4 + cells, showing a significant decrease at Days 3 and 6 post-infection (indicated by ** p < 0.01). (D) Identification of Splenic Treg Populations via scRNA-seq. t-SNE visualisation of splenic cell populations highlighting the Treg_Signature1 cluster. The zoomed-in feature plot confirms the cluster as <t>CD3</t> + , FoxP3 + , and Il2ra + (CD25) regulatory T cells. (E) Comparative t-SNE plots showing the density and distribution of the Treg signature in the spleen at different time points: Mock (ST4), 4 days post-infection (ST5), and 8 days post-infection (ST6). (F) Functional Impact of Ly6G hi vs. Ly6G low Cells on T Cell Activation. Experimental Schematic: CD4 + and CD8 + T cells isolated from the spleen were co-cultured with Ly6G low or Ly6G hi cells from DV-2 infected mice for 3 days, followed by PMA/Ionomycin stimulation and intracellular staining. (G) CD4 + T Cell Cytokine Profile: Intracellular staining for IFN-γ, IL-17, and IL-10 in CD4 + T cells. Co-culture with Ly6G hi cells significantly enhances the frequency of IFN-γ+ and IL-17 + CD4 + T cells (** p < 0.01). (H) Representative plots and bar graphs show a significant increase in the percentage of Granzyme B (GrzB) + and PD-1 + CD8 + T cells when co-cultured with Ly6G hi cells compared to Ly6Glow or Mock (*** p < 0.001).
Anti Cd3 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/InVivoMAb+anti-mouse+CD3%CE%B5/bio_rxiv__64898__2026__10__29__762704-165-18-26
Average 97 stars, based on 1 article reviews
anti cd3 antibody - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

93
Cytek Biosciences anti cd3
( A) Quantitative Analysis of Splenic T Cell Percentages. Line graph tracking the percentage of CD4 + and CD8 + T cells in the spleen from Mock through 4 dpi and 8 dpi. (B) Flow Cytometric Validation of CD4/CD8 Frequency. Representative dot plots showing CD4 vs . CD8 expression in Mock and DV-2 4 dpi spleen samples. (C) The bar graph (right) quantifies the fold change (FC) in CD4 + cells, showing a significant decrease at Days 3 and 6 post-infection (indicated by ** p < 0.01). (D) Identification of Splenic Treg Populations via scRNA-seq. t-SNE visualisation of splenic cell populations highlighting the Treg_Signature1 cluster. The zoomed-in feature plot confirms the cluster as <t>CD3</t> + , FoxP3 + , and Il2ra + (CD25) regulatory T cells. (E) Comparative t-SNE plots showing the density and distribution of the Treg signature in the spleen at different time points: Mock (ST4), 4 days post-infection (ST5), and 8 days post-infection (ST6). (F) Functional Impact of Ly6G hi vs. Ly6G low Cells on T Cell Activation. Experimental Schematic: CD4 + and CD8 + T cells isolated from the spleen were co-cultured with Ly6G low or Ly6G hi cells from DV-2 infected mice for 3 days, followed by PMA/Ionomycin stimulation and intracellular staining. (G) CD4 + T Cell Cytokine Profile: Intracellular staining for IFN-γ, IL-17, and IL-10 in CD4 + T cells. Co-culture with Ly6G hi cells significantly enhances the frequency of IFN-γ+ and IL-17 + CD4 + T cells (** p < 0.01). (H) Representative plots and bar graphs show a significant increase in the percentage of Granzyme B (GrzB) + and PD-1 + CD8 + T cells when co-cultured with Ly6G hi cells compared to Ly6Glow or Mock (*** p < 0.001).
Anti Cd3, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd3/violetFluor+450+Anti-Mouse+CD3/pmc13680497-359-62-63
Average 93 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Proliferation and cytokine production of CD4 + and CD8 + T cells (A and C) Wild-type and NLK-deficient T cells were stimulated with 2 μg/mL plate-bound anti-CD3 with (++) or without (+) 1 μg/mL soluble anti-CD28. (A) Proliferation was measured via [3H]-thymidine uptake. (B) Wild-type and NLK-deficient lymph node and spleen cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28. Proliferation was analyzed by flow cytometry based on CFSE dilution after three days. (C) IL-2 secretion by CD4 + cells and IFN-γ secretion by CD8 + cells was determined with Bio-Plex after one day of stimulation. (D) Wild-type and NLK-deficient CD8 + T cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 6 h or left unstimulated. IFN-γ expression was determined by RT-qPCR and depicted as relative amount to GAPDH; n = 5. Data are represented as mean ± SEM. Paired t test; ∗ p < 0.05.

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet: Proliferation and cytokine production of CD4 + and CD8 + T cells (A and C) Wild-type and NLK-deficient T cells were stimulated with 2 μg/mL plate-bound anti-CD3 with (++) or without (+) 1 μg/mL soluble anti-CD28. (A) Proliferation was measured via [3H]-thymidine uptake. (B) Wild-type and NLK-deficient lymph node and spleen cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28. Proliferation was analyzed by flow cytometry based on CFSE dilution after three days. (C) IL-2 secretion by CD4 + cells and IFN-γ secretion by CD8 + cells was determined with Bio-Plex after one day of stimulation. (D) Wild-type and NLK-deficient CD8 + T cells were stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 6 h or left unstimulated. IFN-γ expression was determined by RT-qPCR and depicted as relative amount to GAPDH; n = 5. Data are represented as mean ± SEM. Paired t test; ∗ p < 0.05.

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques: Flow Cytometry, Expressing, Quantitative RT-PCR

NFATc1 and AP-1 activation Wild-type and NLK-deficient CD8 + T cells were left unstimulated (−) or stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 22 h (++). (A) Nuclear extracts were analyzed on immunoblots to measure nuclear entry of NFATc1. Lamin B1 (LMNB1) was used as a loading control. One representative experiment out of five is shown. (B) Densitometric analysis of five independent immunoblots. Nuclear NFATc1 amounts are relative to loading control. (C) Equal amounts of nuclear extracts were analyzed by electrophoretic mobility shift assay to assess DNA binding of NFATc1. For supershift, 1 μg anti-NFATc1 was added to the binding reaction. One representative experiment out of three is shown. (D) Nuclear extracts were analyzed by electrophoretic mobility shift assay to assess DNA binding of AP-1. One experiment out of two with similar results is shown. Paired t test; ∗ p < 0.05.

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet: NFATc1 and AP-1 activation Wild-type and NLK-deficient CD8 + T cells were left unstimulated (−) or stimulated with 2 μg/mL plate-bound anti-CD3 and 1 μg/mL soluble anti-CD28 for 22 h (++). (A) Nuclear extracts were analyzed on immunoblots to measure nuclear entry of NFATc1. Lamin B1 (LMNB1) was used as a loading control. One representative experiment out of five is shown. (B) Densitometric analysis of five independent immunoblots. Nuclear NFATc1 amounts are relative to loading control. (C) Equal amounts of nuclear extracts were analyzed by electrophoretic mobility shift assay to assess DNA binding of NFATc1. For supershift, 1 μg anti-NFATc1 was added to the binding reaction. One representative experiment out of three is shown. (D) Nuclear extracts were analyzed by electrophoretic mobility shift assay to assess DNA binding of AP-1. One experiment out of two with similar results is shown. Paired t test; ∗ p < 0.05.

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques: Activation Assay, Western Blot, Control, Analysis, Electrophoretic Mobility Shift Assay, Binding Assay

Flow cytometric and RNA-seq analyses of MC38 tumor-infiltrating lymphocytes Flow cytometric analyses were performed three weeks after MC38 injection. (A) Percentage of immune cells (CD45 + ), T cells (CD4 + or CD8 + ), B cells (CD19 + ), NK cells (CD3 − NK1.1 + ), and NKT cells (CD3 + NK1.1 + ). (B) Distribution of CD4 + naive (CD62L + CD44 − ), central memory (CD62L + CD44 + ), effector memory (CD62L − CD44 + ), regulatory (Foxp3 + CD25 + ), and CD8 + CD69 + T cells. (C) Intracellular staining of cytokines in CD4 + and CD8 + T cells after stimulation with phorbol-12,13-dibutyrate and ionomycin (P/I) for 4 h. (D) Volumes of the MC38 tumors used in the RNA-seq experiments. (E–H) RNA-seq analyses of CD8 + TILs were performed on normalized gene expression profiles obtained from RNA sequencing of tumor-infiltrating CD8 + T cells isolated from four NLK +/+ and four NLK fl/fl mice three weeks after MC38 injection. (E) Principal component analysis (PCA). The plot shows the separation of samples based on DESeq2-normalized overall transcriptomic profiles. (F) Clustered heatmap of differentially expressed genes (DEGs), defined as log2 fold change ≥1 and p adj ≤0.05. Due to space limitations, some genes that are located below each other in the heatmap are written next to each other. (G) Heatmap of cytotoxicity-related genes. (F and G) Robust Z scores are based on median and interquartile range. (H) Gene set enrichment analysis (GSEA) plots for the indicated KEGG pathways. Normalized enrichment score (NES) and adjusted p value ( p adj) are shown. (A–C) Data are shown as mean ± SEM. Unpaired t test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet: Flow cytometric and RNA-seq analyses of MC38 tumor-infiltrating lymphocytes Flow cytometric analyses were performed three weeks after MC38 injection. (A) Percentage of immune cells (CD45 + ), T cells (CD4 + or CD8 + ), B cells (CD19 + ), NK cells (CD3 − NK1.1 + ), and NKT cells (CD3 + NK1.1 + ). (B) Distribution of CD4 + naive (CD62L + CD44 − ), central memory (CD62L + CD44 + ), effector memory (CD62L − CD44 + ), regulatory (Foxp3 + CD25 + ), and CD8 + CD69 + T cells. (C) Intracellular staining of cytokines in CD4 + and CD8 + T cells after stimulation with phorbol-12,13-dibutyrate and ionomycin (P/I) for 4 h. (D) Volumes of the MC38 tumors used in the RNA-seq experiments. (E–H) RNA-seq analyses of CD8 + TILs were performed on normalized gene expression profiles obtained from RNA sequencing of tumor-infiltrating CD8 + T cells isolated from four NLK +/+ and four NLK fl/fl mice three weeks after MC38 injection. (E) Principal component analysis (PCA). The plot shows the separation of samples based on DESeq2-normalized overall transcriptomic profiles. (F) Clustered heatmap of differentially expressed genes (DEGs), defined as log2 fold change ≥1 and p adj ≤0.05. Due to space limitations, some genes that are located below each other in the heatmap are written next to each other. (G) Heatmap of cytotoxicity-related genes. (F and G) Robust Z scores are based on median and interquartile range. (H) Gene set enrichment analysis (GSEA) plots for the indicated KEGG pathways. Normalized enrichment score (NES) and adjusted p value ( p adj) are shown. (A–C) Data are shown as mean ± SEM. Unpaired t test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques: RNA Sequencing, Injection, Staining, Gene Expression, Isolation, Analysis, Gene Set Enrichment Analysis, Cell Differentiation

NLK restrains acute human T cell activation and effector functions Primary human CD3 + T cells were lentivirally engineered to express either NLK (red) or a control construct (black), followed by puromycin selection for NLK transgene expressing cells. Modified T cells were subsequently subjected to phenotypic and functional analyses. (A) Schematic overview of constructs used for NLK overexpression or corresponding control. (B) Confirmation of NLK overexpression by RT-qPCR on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies and western blot without restimulation. β-actin (ACTB) was used as a loading control. (C) Flow cytometric analysis of CD25 expression on day 10, at the end of production. (D) Intracellular flow cytometric analysis of cytokine production (IL-2, IFN-γ, and GZMB) on day 10 upon 4 h restimulation via 5 μg/mL anti-CD3 antibodies in the presence of brefeldin A and monensin added 45 min post re-stimulation. (E) Bioplex analysis on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies measuring cytokine concentrations from supernatants. (F) Proliferation analysis: Fold change of cell counts during expansion phase after transduction with NLK transgene between day 1 and 10 (left) together with flow cytometric analysis of Ki-67 expression on day 1, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies (right). (G) Equal amounts of nuclear extracts of human CD3 + T cells were analyzed by electrophoretic mobility shift assays to assess DNA binding of NFATc1 and AP-1 on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies. (H) Flow cytometric analysis of inhibitory marker (co-)expression on day 11, after 24 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies. All data originate from n = 4 donors and are represented as connected individual donor data points. Paired t test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet: NLK restrains acute human T cell activation and effector functions Primary human CD3 + T cells were lentivirally engineered to express either NLK (red) or a control construct (black), followed by puromycin selection for NLK transgene expressing cells. Modified T cells were subsequently subjected to phenotypic and functional analyses. (A) Schematic overview of constructs used for NLK overexpression or corresponding control. (B) Confirmation of NLK overexpression by RT-qPCR on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies and western blot without restimulation. β-actin (ACTB) was used as a loading control. (C) Flow cytometric analysis of CD25 expression on day 10, at the end of production. (D) Intracellular flow cytometric analysis of cytokine production (IL-2, IFN-γ, and GZMB) on day 10 upon 4 h restimulation via 5 μg/mL anti-CD3 antibodies in the presence of brefeldin A and monensin added 45 min post re-stimulation. (E) Bioplex analysis on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies measuring cytokine concentrations from supernatants. (F) Proliferation analysis: Fold change of cell counts during expansion phase after transduction with NLK transgene between day 1 and 10 (left) together with flow cytometric analysis of Ki-67 expression on day 1, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies (right). (G) Equal amounts of nuclear extracts of human CD3 + T cells were analyzed by electrophoretic mobility shift assays to assess DNA binding of NFATc1 and AP-1 on day 11, after 20 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies. (H) Flow cytometric analysis of inhibitory marker (co-)expression on day 11, after 24 h restimulation via 5 μg/mL plate-bound anti-CD3 antibodies. All data originate from n = 4 donors and are represented as connected individual donor data points. Paired t test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques: Activation Assay, Control, Construct, Selection, Expressing, Modification, Functional Assay, Over Expression, Quantitative RT-PCR, Western Blot, Analysis, Transduction, Electrophoretic Mobility Shift Assay, Binding Assay, Marker

NLK preserves cytotoxic capacity during chronic stimulation of CAR-T cells Primary human CD3 + T cells were lentivirally engineered to express an anti-EGFR CAR together with either NLK (red) or a control construct (black), followed by puromycin selection for NLK transgene and MACS-based enrichment of CAR-expressing cells. Modified T cells were subsequently subjected to phenotypic and functional analyses. (A) Scheme of CAR and target cell model system. (B) Killing assay: NLK-modified CAR T cells were co-cultured with A549 eGFP B2M −/− target cells at an effector-to-target (E:T) ratio of 4:1. Tumor cell killing was monitored by live-cell imaging every 2 h. Left: killing curves. Tot. int. int. = total integrated intensity; GCU = green channel units. Right: representative microscopic fluorescent figure at start (0) and after 36 h of co-culture (scale bars, 400 μM). (C) Bioplex analysis measuring GZMB concentrations from supernatants at the end of co-culture (6 days of killing). (D) Cell counts of viable T cells per well at the end of co-culture (6 days of killing) determined by flow cytometry. (E–G) Analysis of activation and cytokine production abilities after stress test, where NLK -modified CAR T cells were co-cultured with A549 eGFP B2M −/− target cells at an effector-to-target (E:T) ratio of 4:1 with target cells being replenished every 48 h for in total 10 days. (E) Flow cytometric analysis of CD25 expression. (F and G) Intracellular flow cytometric analysis of cytokine production (IL-2, IFN-γ, and GZMB) of CD4 + and CD8 + cells on day 10 upon 3.5 h restimulation via P/I in the presence of brefeldin A and monensin added 30 min post re-stimulation. All data originate from n = 4 donors and are represented as connected individual donor data points. Paired t test (or mixed-effect analysis followed by multiple comparisons at every time point controlled by false discovery rate [FDR] for killing shown in [B]); ∗ p < 0.05, ∗∗∗∗ p < 0.0001.

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet: NLK preserves cytotoxic capacity during chronic stimulation of CAR-T cells Primary human CD3 + T cells were lentivirally engineered to express an anti-EGFR CAR together with either NLK (red) or a control construct (black), followed by puromycin selection for NLK transgene and MACS-based enrichment of CAR-expressing cells. Modified T cells were subsequently subjected to phenotypic and functional analyses. (A) Scheme of CAR and target cell model system. (B) Killing assay: NLK-modified CAR T cells were co-cultured with A549 eGFP B2M −/− target cells at an effector-to-target (E:T) ratio of 4:1. Tumor cell killing was monitored by live-cell imaging every 2 h. Left: killing curves. Tot. int. int. = total integrated intensity; GCU = green channel units. Right: representative microscopic fluorescent figure at start (0) and after 36 h of co-culture (scale bars, 400 μM). (C) Bioplex analysis measuring GZMB concentrations from supernatants at the end of co-culture (6 days of killing). (D) Cell counts of viable T cells per well at the end of co-culture (6 days of killing) determined by flow cytometry. (E–G) Analysis of activation and cytokine production abilities after stress test, where NLK -modified CAR T cells were co-cultured with A549 eGFP B2M −/− target cells at an effector-to-target (E:T) ratio of 4:1 with target cells being replenished every 48 h for in total 10 days. (E) Flow cytometric analysis of CD25 expression. (F and G) Intracellular flow cytometric analysis of cytokine production (IL-2, IFN-γ, and GZMB) of CD4 + and CD8 + cells on day 10 upon 3.5 h restimulation via P/I in the presence of brefeldin A and monensin added 30 min post re-stimulation. All data originate from n = 4 donors and are represented as connected individual donor data points. Paired t test (or mixed-effect analysis followed by multiple comparisons at every time point controlled by false discovery rate [FDR] for killing shown in [B]); ∗ p < 0.05, ∗∗∗∗ p < 0.0001.

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques: Control, Construct, Selection, Expressing, Modification, Functional Assay, Cell Culture, Live Cell Imaging, Co-culture Assay, Analysis, Flow Cytometry, Activation Assay

Journal: iScience

Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

doi: 10.1016/j.isci.2026.118070

Figure Lengend Snippet:

Article Snippet: For polyclonal stimulation in vitro , cell culture plates were coated with the indicated concentration of anti-CD3ε antibodies (BioXcell; clone 145-2C11; BE0001-1 for mouse or Bio-X-Cell; clone OKT3; BE0001-2 for human) in PBS.

Techniques:

( A) Quantitative Analysis of Splenic T Cell Percentages. Line graph tracking the percentage of CD4 + and CD8 + T cells in the spleen from Mock through 4 dpi and 8 dpi. (B) Flow Cytometric Validation of CD4/CD8 Frequency. Representative dot plots showing CD4 vs . CD8 expression in Mock and DV-2 4 dpi spleen samples. (C) The bar graph (right) quantifies the fold change (FC) in CD4 + cells, showing a significant decrease at Days 3 and 6 post-infection (indicated by ** p < 0.01). (D) Identification of Splenic Treg Populations via scRNA-seq. t-SNE visualisation of splenic cell populations highlighting the Treg_Signature1 cluster. The zoomed-in feature plot confirms the cluster as CD3 + , FoxP3 + , and Il2ra + (CD25) regulatory T cells. (E) Comparative t-SNE plots showing the density and distribution of the Treg signature in the spleen at different time points: Mock (ST4), 4 days post-infection (ST5), and 8 days post-infection (ST6). (F) Functional Impact of Ly6G hi vs. Ly6G low Cells on T Cell Activation. Experimental Schematic: CD4 + and CD8 + T cells isolated from the spleen were co-cultured with Ly6G low or Ly6G hi cells from DV-2 infected mice for 3 days, followed by PMA/Ionomycin stimulation and intracellular staining. (G) CD4 + T Cell Cytokine Profile: Intracellular staining for IFN-γ, IL-17, and IL-10 in CD4 + T cells. Co-culture with Ly6G hi cells significantly enhances the frequency of IFN-γ+ and IL-17 + CD4 + T cells (** p < 0.01). (H) Representative plots and bar graphs show a significant increase in the percentage of Granzyme B (GrzB) + and PD-1 + CD8 + T cells when co-cultured with Ly6G hi cells compared to Ly6Glow or Mock (*** p < 0.001).

Journal: bioRxiv

Article Title: Dengue Virus Serotype 2 Infection Transcriptionally Reprograms Host Neutrophils to Establish an Immunosuppressive Microenvironment in Mice

doi: 10.64898/2026.10.29.762704

Figure Lengend Snippet: ( A) Quantitative Analysis of Splenic T Cell Percentages. Line graph tracking the percentage of CD4 + and CD8 + T cells in the spleen from Mock through 4 dpi and 8 dpi. (B) Flow Cytometric Validation of CD4/CD8 Frequency. Representative dot plots showing CD4 vs . CD8 expression in Mock and DV-2 4 dpi spleen samples. (C) The bar graph (right) quantifies the fold change (FC) in CD4 + cells, showing a significant decrease at Days 3 and 6 post-infection (indicated by ** p < 0.01). (D) Identification of Splenic Treg Populations via scRNA-seq. t-SNE visualisation of splenic cell populations highlighting the Treg_Signature1 cluster. The zoomed-in feature plot confirms the cluster as CD3 + , FoxP3 + , and Il2ra + (CD25) regulatory T cells. (E) Comparative t-SNE plots showing the density and distribution of the Treg signature in the spleen at different time points: Mock (ST4), 4 days post-infection (ST5), and 8 days post-infection (ST6). (F) Functional Impact of Ly6G hi vs. Ly6G low Cells on T Cell Activation. Experimental Schematic: CD4 + and CD8 + T cells isolated from the spleen were co-cultured with Ly6G low or Ly6G hi cells from DV-2 infected mice for 3 days, followed by PMA/Ionomycin stimulation and intracellular staining. (G) CD4 + T Cell Cytokine Profile: Intracellular staining for IFN-γ, IL-17, and IL-10 in CD4 + T cells. Co-culture with Ly6G hi cells significantly enhances the frequency of IFN-γ+ and IL-17 + CD4 + T cells (** p < 0.01). (H) Representative plots and bar graphs show a significant increase in the percentage of Granzyme B (GrzB) + and PD-1 + CD8 + T cells when co-cultured with Ly6G hi cells compared to Ly6Glow or Mock (*** p < 0.001).

Article Snippet: To investigate the immunomodulatory effect of FGL2 on T-cell responses, splenocytes were cultured in a plate pre-coated with anti-CD3 antibody (2.0 μg ml −1 , 145-2C11, BioXcell).

Techniques: Analysis, Biomarker Discovery, Expressing, Infection, Functional Assay, Activation Assay, Isolation, Cell Culture, Staining, Co-culture Assay

(A) Splenocytes were stimulated with anti-CD3 ± anti-CD28 in the presence or absence of recombinant FGL2 or FGL2 alone. Flow cytometric analysis revealed reduced frequencies of CD4⁺IFN-γ⁺ and CD4⁺TNF-α⁺ effector T cells, alongside increased CD4⁺PD-1⁺ and CD25⁺Foxp3⁺ regulatory T cells following FGL2 treatment, indicating suppressed activation and enhanced inhibitory signalling (n=3). (B) Intracellular analysis of CD8⁺ T cells demonstrated reduced IFN-γ, TNF-α, and perforin production, with increased PD-1 expression in the presence of FGL2, consistent with an immunosuppressive/exhausted phenotype. Data are representative of independent experiments(n=3). *p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: bioRxiv

Article Title: Dengue Virus Serotype 2 Infection Transcriptionally Reprograms Host Neutrophils to Establish an Immunosuppressive Microenvironment in Mice

doi: 10.64898/2026.10.29.762704

Figure Lengend Snippet: (A) Splenocytes were stimulated with anti-CD3 ± anti-CD28 in the presence or absence of recombinant FGL2 or FGL2 alone. Flow cytometric analysis revealed reduced frequencies of CD4⁺IFN-γ⁺ and CD4⁺TNF-α⁺ effector T cells, alongside increased CD4⁺PD-1⁺ and CD25⁺Foxp3⁺ regulatory T cells following FGL2 treatment, indicating suppressed activation and enhanced inhibitory signalling (n=3). (B) Intracellular analysis of CD8⁺ T cells demonstrated reduced IFN-γ, TNF-α, and perforin production, with increased PD-1 expression in the presence of FGL2, consistent with an immunosuppressive/exhausted phenotype. Data are representative of independent experiments(n=3). *p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: To investigate the immunomodulatory effect of FGL2 on T-cell responses, splenocytes were cultured in a plate pre-coated with anti-CD3 antibody (2.0 μg ml −1 , 145-2C11, BioXcell).

Techniques: Recombinant, Analysis, Activation Assay, Expressing